Vanda Pharmaceuticals
VNDA
#8787
Rank
S$0.29 B
Marketcap
S$4.89
Share price
6.41%
Change (1 day)
-14.97%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): S$0.37

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$5.93. In 2022 the company made an earnings per share (EPS) of S$0.15 a decrease over its 2021 EPS that were of S$0.77.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$0.37139.11%
2022S$0.15-80%
2021S$0.7739.53%
2020S$0.55-80.18%
2019S$2.78334%
2018S$0.64-247.06%
2017S-$0.44-19.05%
2016S-$0.54-55.32%
2015S-$1.20-347.37%
2014S$0.49-156.72%
2013S-$0.86-31.63%
2012S-$1.25172.22%
2011S-$0.46-238.46%
2010S$0.33-119.7%
2009S-$1.69-31.61%
2008S-$2.47-31.32%
2007S-$3.60-99.27%
2006S-$496.1336045.14%
2005S-$1.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.56-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.72-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.52-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.27-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.79-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
S-$5.62-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA